Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PKP4 antisense RNA 1 (PKP4-AS1) is a long non-coding RNA gene identified in humans, which is transcribed from the opposite strand to the PKP4 (Plakophilin 4) gene. As an antisense RNA, its principal role is presumed to involve the regulation of its sense partner gene, PKP4, likely through mechanisms such as transcriptional interference, RNA-RNA binding, or by affecting chromatin structure. There are no direct annotations for PKP4-AS1 in major gene function databases regarding its biological role, disease associations, or drug interactions[1]. PKP4 itself is involved in cellular junctions and cytoskeletal organization, but the specific impact of PKP4-AS1 remains uncharacterized. PKP4-AS1 is not considered a traditional therapeutic target such as a receptor, enzyme, or transporter and currently lacks evidence of direct association with human disease or pharmacological intervention[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plakophilin 4 antisense RNA 1 (PKP4-AS1).